Atrial fibrillation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >= 30 and <= 90 years old 2. Subjects with atrial fibrillation and had undergone at least one time of ablation and has been confirmed to recur outside 3 months after the last ablation; 3. Subjects who agreed to participate in this study and were willing to sign an informed consent; 4. Being able to complete the study according to the research protocols, including ablation prodedure and follow-up.
Exclusion criteria
Exclusion criteria: 1. Atrial fibrillation induced by reversible causes, such as untreated hyperthyroidism; 2. Severe organic heart disease such as severe mitral stenosis or reflux, severe aortic stenosis or reflux, hypertrophic obstructive cardiomyopathy, dilated cardiomyopathy, and restrictive cardiomyopathy; 3. Thrombosis or tumors in the atrium; 4. The anterior posterior diameter of left atrium >55mm (2D echocardiography, parasternal long axis view); 5. Contraindications to heparin or oral anticoagulants; 6. Creatinine clearance rate less than 30ml/min; 7. Pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Within 12 months of follow-up after "4E" ablation, no episodes of atrial tachyarrhythmias including atrial fibrillation, atrial flutter, and atrial tachycardia and lasting more than 30 seconds without antiarrhythmic drugs, three months after alation was a blank period; | — |
Secondary
| Measure | Time frame |
|---|---|
| Follow up for 12 months after catheter radiofrequency ablation showed no atrial fibrillation events lasting>30 seconds without antiarrhythmic drugs;Follow up for 12 months after catheter radiofrequency ablation showed no atrial flutter events lasting>30 seconds without antiarrhythmic drugs;Follow up for 12 months after catheter radiofrequency ablation showed no atrial tachycardia events lasting>30 seconds without antiarrhythmic drugs;Incidence of complications during the perioperative and follow-up periods;Ablation time;The relationship between intraoperative atrial fibrillation ablation termination and postoperative success rate; | — |
Countries
China
Contacts
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine